Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The September 2024 LIFT-AD trial termination after meeting enrollment demonstrates that this approach, despite decades of development, does not slow Alzheimer's cognitive decline in humans
Read that number again
Specifically, researchers want to ensure that compounds promoting rapid cell growth and new blood vessel formation do not inadvertently accelerate the growth of harmful, abnormal cells
The TRIUMPH-4 Phase 3 trial in obesity with knee osteoarthritis (Bays et al., NEJM 2025) reported 28.7% mean weight loss at 68 weeks at the 12 mg dose, plus a 75.8% reduction in WOMAC knee pain scores
For topical GHK-Cu, that usually means applying a small, consistent amount once or twice daily
Simpson says peptides come in pills, injectables and now nasal sprays
US$ 29.19
US$ 22.32
US$ 29.21
US$ 28.74
US$ 29.02
